Navigation Links
Savient's Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase
Date:11/19/2008

FORWARD-LOOKING LANGUAGE

All statements other than statements of historical facts included in this press release are forward-looking statements that are subject to certain risks, trends and uncertainties that could cause actual results and achievements to differ materially from those expressed in such statements. These risks, trends and uncertainties are in some instances beyond our control. Words such as "anticipate," "believe," "estimate," "expect," "intend," "plan," "will" and other similar expressions help identify forward-looking statements, although not all forward-looking statements contain these identifying words. In particular, any statements regarding our BLA filing with the FDA, a potential Advisory Committee, approval of the BLA, preparation for commercialization of pegloticase, the efficacy and safety of pegloticase, the market for pegloticase, and the absence of other therapies for treatment-failure gout patients, are forward-looking statements. These forward-looking statements involve substantial risks and uncertainties and are based on our current assessment of the Phase 3 clinical data and on current expectations, assumptions, estimates and projections about our business and the biopharmaceutical and specialty pharmaceutical industries in which we operate. Important factors that may affect our ability to achieve the matters addressed in these forward-looking statements include, but are not limited to, the delay or failure in completing development of pegloticase and developing other product candidates; our stock price and market conditions; varying interpretations of our clinical and CMC data by the FDA; delay achieving or failure to achieve FDA approval of pegloticase; inability to manufacture commercial quantities of our products; inability to gain market acceptance sufficient to justify development and commercialization costs if our products are approved for marketing; our continuing to incur substanti
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
2. Richard Greco Joins Mediware Board
3. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
4. Award-winning QUITPLAN(R) Services Billboard Debuts in Rogers
5. Montana Health Care Leader Elected Board Chair of National Association
6. Genaera Announces Formation of Scientific Advisory Board for Obesity Drug Candidate Trodusquemine (MSI-1436)
7. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
8. Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting
9. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
10. Patient Safety Authority Board of Directors Names Infection Advisory Panel
11. William Moore Appointed to IRIDEX Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 31, 2014 (HealthDay News) -- Sleep apnea may make it ... you parked your car or left your house keys, a ... sleep apnea showed that this ability -- called spatial memory ... (REM) sleep, even when other stages of sleep weren,t affected. ... dreams typically occur. "We,ve shown for the first time ...
(Date:10/31/2014)... Americans say that either they or a family member ... the latest issue of The Gerontological Society of America,s ... ), which goes on to show that Americans strongly ... patients, end-of-life health care wishes. , This PP&AR ... ," features 12 articles that present new ways of ...
(Date:10/31/2014)... 2014 North Shore Eye Care today ... Long Island and the addition of leading ophthalmologist, William ... to North Shore Eye Care Medical Director, Jeffrey Martin, ... of the Department of Ophthalmology of Winthrop-University Hospital and ... City for more than 30 years. He has been ...
(Date:10/31/2014)... York, NY (PRWEB) October 31, 2014 ... of the most remarkable gifts of life — building ... for matching extraordinary surrogate mothers and donors with hopeful ... individuals in unforeseen circumstances. , It’s a collective aptitude ... surrogacy agencies, surrogacy lawyers, and fertility clinics that help ...
(Date:10/31/2014)... BCC Research ( http://www.bccresearch.com ) reveals in its new ... U.S. indoor air quality (IAQ) market is expected to grow ... rate (CAGR) of 7% over the next five years. The ... of 7.4%. , Since 2012, continuing media attention focused ... infectious diseases such as bird flu and the increase in ...
Breaking Medicine News(10 mins):Health News:Sleep Apnea May Steal Some of Your Memory: Study 2Health News:Advance directives can benefit patients, families, and health care system 2Health News:William Kasper, MD Garden City Ophthalmologist, Joins Medical Staff at North Shore Eye Care 2Health News:William Kasper, MD Garden City Ophthalmologist, Joins Medical Staff at North Shore Eye Care 3Health News:Over 800 New Surrogate Mother Members at FindSurrogateMother.com Helping Create Pathways to Parenthood 2Health News:Over 800 New Surrogate Mother Members at FindSurrogateMother.com Helping Create Pathways to Parenthood 3Health News:Global Market for U.S. Indoor Air Quality (IAQ) to Reach $11.4 Billion by 2019; Equipment Market Segment Surging at 7.4% CAGR 2Health News:Global Market for U.S. Indoor Air Quality (IAQ) to Reach $11.4 Billion by 2019; Equipment Market Segment Surging at 7.4% CAGR 3
... INCREASE 23 PERCENTSAN DIEGO, Feb. 17 Volcano Corporation ... development, manufacturing and sales of products for the diagnosis ... reported that revenues for the full year 2008 increased ... for the fourth quarter of 2008 increased 23 percent ...
... and those also taking steroids are most vulnerable, study ... class of medications used widely to treat rheumatoid arthritis ... shingles, especially among older people and those who are ... appearing in the Feb. 18 issue of the ...
... Foresight Credited with Industry,s Strong Business Performance in Tough ... economy in crisis, it,s clear that strong domestic industries ... Food and Drug Administration (FDA) mandated trans fat appear ... products to reduce or eliminate trans fat content. ...
... and partners,of Greenway Medical Technologies, led by the ... Barnes, recently returned from,Washington, D.C. where they played ... healthcare information technology (HIT) portion of,the $787 billion ... law. , Greenway,s leadership ...
... alleviate the stress of trying to figure out the ,Nanny ... - there are two things parents never imagined ... of America,s most exciting female political figures having issues due ... an issue. That,s why Sittercity.com, America,s largest and most ...
... Feb. 17 National Pharmaceutical Council President Dan ... economic stimulus package, which includes $1.1 billion for ... package into law, President Obama has made a ... for comparative effectiveness research also is a major ...
Cached Medicine News:Health News:Volcano Reports Full Year Revenues Increase 31 Percent 2Health News:Volcano Reports Full Year Revenues Increase 31 Percent 3Health News:Volcano Reports Full Year Revenues Increase 31 Percent 4Health News:Volcano Reports Full Year Revenues Increase 31 Percent 5Health News:Volcano Reports Full Year Revenues Increase 31 Percent 6Health News:Volcano Reports Full Year Revenues Increase 31 Percent 7Health News:Volcano Reports Full Year Revenues Increase 31 Percent 8Health News:Volcano Reports Full Year Revenues Increase 31 Percent 9Health News:Volcano Reports Full Year Revenues Increase 31 Percent 10Health News:Volcano Reports Full Year Revenues Increase 31 Percent 11Health News:Volcano Reports Full Year Revenues Increase 31 Percent 12Health News:Volcano Reports Full Year Revenues Increase 31 Percent 13Health News:Volcano Reports Full Year Revenues Increase 31 Percent 14Health News:Rheumatoid Arthritis Drugs Raise Shingles Risk 2Health News:Rheumatoid Arthritis Drugs Raise Shingles Risk 3Health News:Farmers' Trans Fat Solution Efforts Preserve $700 Million Market 2Health News:Farmers' Trans Fat Solution Efforts Preserve $700 Million Market 3Health News:Greenway Medical Technologies Assists Capitol Hill With Shaping of The President's Stimulus Package 2Health News:Greenway Medical Technologies Assists Capitol Hill With Shaping of The President's Stimulus Package 3Health News:Sittercity.com Makes Nanny Taxes Less Taxing 2Health News:Sittercity.com Makes Nanny Taxes Less Taxing 3
(Date:10/31/2014)... YORK , Oct. 31, 2014 Though ... cell technologies are expected to show an annual increase ... market value of nearly $1 billion, according to Kalorama ... revenues from proprietary stem cell therapeutics that have gained ... authorities. "As drug developers tackle ever more ...
(Date:10/30/2014)... Oct. 30, 2014   NxStage® Kidney Care, Inc ., ... ), is proud to host the grand opening ceremony of ... 1600 W. 16 th Street on November 20, 2014 ... highly trained medical staff who are committed to providing patients ... life benefits made possible through more flexible dialysis treatment options.   ...
(Date:10/30/2014)... Oct. 30, 2014   ViaDerma, Inc. ... bringing new products to market, has recently released ... TetraStem is a topical liquid tetracycline-based antibiotic that ... can convert oral medication active ingredients into topical ... first aid antibiotic to help prevent skin infection ...
Breaking Medicine Technology:Report: Stem Cell Technologies Market Growing 2Grand Opening of NxStage Kidney Care Oak Brook IL Center 2Grand Opening of NxStage Kidney Care Oak Brook IL Center 3ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 3
... Henry Schein, Inc. (NASDAQ: HSIC ), ... office-based practitioners, announced today that Ferdinand Jahnel, Vice ... King 9th Annual Best Ideas Conference 2011. The conference is ... City. Henry Schein,s presentation is scheduled to ...
... 2011 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ... and chief executive officer, will present at the following upcoming ... UBS Global Life Sciences Conference Tuesday, September 20, 2011 ... JMP Securities Healthcare Conference Tuesday, September 27, 2011 2:30 ...
Cached Medicine Technology:Henry Schein to Present at the CL King 9th Annual Best Ideas Conference 2011 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: